Search
for

    Sort by

    Research 121–150 of 1000+

    1. Advances in Chitosan-Based Nanoparticles for Drug Delivery International Journal of Molecular Sciences · 2021 · 96 citations
    2. Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors Uro · 2021 · 6 citations
    3. COVID‐19, androgens, and androgenic alopecia Dermatological reviews · 2020 · 6 citations
    4. Review of Drug Repositioning in Cancer Therapeutics Asian Journal of Research in Chemistry · 2024
    5. Toxic Epidermal Necrolysis Medical Clinics of North America · 1980 · 74 citations
    6. Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19? Journal of Cosmetic Dermatology · 2020 · 71 citations
    7. What do we know about phytotherapy of benign prostatic hyperplasia? Life Sciences · 2015 · 67 citations
    8. Adverse Cutaneous Reactions to Antipsychotics American Journal of Clinical Dermatology · 2002 · 64 citations
    9. Ovarian Hypertension: Polycystic Ovary Syndrome Endocrinology and Metabolism Clinics of North America · 2011 · 60 citations
    10. Adverse Cutaneous Reactions to Antidepressants American Journal of Clinical Dermatology · 2002 · 44 citations
    11. Polycystic ovary syndrome: A review for dermatologists Journal of The American Academy of Dermatology · 2014 · 30 citations
    12. Laser-Assisted Drug Delivery: A Systematic Review of Safety and Adverse Events Pharmaceutics · 2022 · 21 citations
    13. Systemic causes of hair loss Annals of Medicine · 2016 · 18 citations
    14. Hair loss Postgraduate Medicine · 1989 · 12 citations
    15. Women’s Health Considerations for Lipid Management Cardiology Clinics · 2015 · 9 citations
    16. Hirsutism – From Diagnosis to Use of Antiandrogens Frontiers of Hormone Research · 2012 · 9 citations
    17. Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024 Pharmaceuticals · 2025 · 8 citations
    18. Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease Pharmaceutics · 2024 · 5 citations
    19. Laser-assisted Hair Regrowth Plastic and reconstructive surgery. Global open · 2019 · 5 citations
    20. The Skin and Subcutaneous Tissues Springer eBooks · 2013 · 1 citations
    21. Drug repurposing—a promising approach for patients with angina but non-obstructive coronary artery disease (ANOCA) Frontiers in Cardiovascular Medicine · 2023
    22. Clinico-Epidemiological Aspects of Cutaneous Lesions in Injecting Drug Users Visiting an Oral Substitution Therapy Centre: A Cross-Sectional Study Dermatology practical & conceptual · 2022
    23. Drug Repurposing Patent Applications April–June 2021 Assay and drug development technologies · 2021
    24. Self-Assessment Elsevier eBooks · 2019
    25. Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis European Journal of Medical Research · 2023
    26. Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014) Age and Ageing · 2015 · 111 citations
    27. Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning Frontiers in Pharmacology · 2024 · 15 citations
    28. Formulation and optimization of folate-bovine serum albumin-coated ethoniosomes of pterostilbene as a targeted drug delivery system for lung cancer: In vitro and in vivo demonstrations Cancer Nanotechnology · 2023 · 20 citations
    29. Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care Journal of Human Hypertension · 2023 · 4 citations
    30. Response to “The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System” Journal of Cosmetic Dermatology · 2025